Demant reported stronger growth in the second quarter (Q2) of 2026, led by continued momentum in its Hearing Aids business and particularly strong performance in North America. The Danish hearing healthcare group—parent company of Oticon , Bernafon , Audica, HearingLife , and some of the hearing industry’s largest special equipment manufacturers—also raised its full-year financial outlook following the...
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a financial performance report with no clinical or practice-management implications.
Demant's upward-revised outlook signals continued market growth in hearing aids, which may reflect broader adoption trends relevant to clinic owners and the competitive landscape.
- 01Demant reported stronger-than-expected Q2 2026 growth in its Hearing Aids segment.
- 02North American performance was a key driver of the positive results.
- 03The company raised its full-year 2026 financial outlook following the strong quarter.
- 04Growth in hearing aid sales may reflect expanding consumer demand or successful product cycles.
Demant's Hearing Aids segment drove stronger Q2 2026 growth.
press releasesupportedNorth American performance was a key contributor to Demant's Q2 2026 results.
press releasesupportedDemant raised its full-year 2026 financial outlook.
press releasesupported
